Germany - Drugs

For more information and to make a bid you will need to go to the third party website.

Details

Provided by Open Opps
Opportunity closing date
28 February 2025
Opportunity publication date
22 March 2023
Category
33600000
Value of contract
to be confirmed
Your guide to exporting
Report opportunity

Description

The subject of this publication is the conclusion of non-exclusive rebate contracts pursuant to Section 130a (8) SGB V for finished medicinal products with the active ingredient combination vilanterol and fluticasone furoate (ATC: R03AK10) within the framework of a so-called "open-house model". All suitable and interested pharmaceutical companies or associations of pharmaceutical companies are offered the opportunity to conclude or join a rebate contract in accordance with Section 130a (8) of the German Social Code, Book V for the active ingredients listed in Section B, subject to uniform contract conditions and a uniform access procedure. Interested pharmaceutical companies can request the participation documents and the respective contract from the contact address mentioned under I.1). A prerequisite for the conclusion of an agreement is that the interested pharmaceutical company submits the requested participation documents completely filled out and signed.
Conclusion of non-exclusive discount agreements in accordance with Section 130a (8) of the German Social Code, Book V for finished medicinal products with the active ingredient combination vilanterol and fluticasone furoate (ATC: R03AK10) with the possibility of conclusion at any time within the framework of a so-called "open-house model". A contract is concluded with each pharmaceutical company that meets the participation requirements. There is no exclusivity and the contract can be concluded at any time and under the same conditions. Individual contract negotiations are not carried out. The earliest start of the contract is 01.05.2023.Based on this, the contract period is a maximum of 24 months. The contract ends on 30.04.2025 regardless of the start date. Should AOK Saxony-Anhalt invite tenders for exclusive contracts for the active ingredients during the term of the contract in accordance with the relevant provisions of public procurement law, the contracts concluded under this publication will be terminated in accordance with the contractual provisions.This publication does not constitute the award of a public contract within the meaning of Section 103 GWB or public procurement law. In order to ensure the greatest possible degree of transparency for the intended contract conclusions, the publication is made in the Supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice is used. The resulting conceptual specifications, such as the procedural designation "open procedure", are solely due to the use of this publication form and the publication platform. Any further meaning, in particular a submission to procurement law regulations, unless they are mandatory for legal reasons, is not associated with this.

Opportunity closing date
28 February 2025
Value of contract
to be confirmed

About the buyer

Address
AOK Sachsen-Anhalt Lüneburger Str. 4 Magdeburg 39106 Germany
Contact
openhouse@san.aok.de

Bid for tender

If your company meets the requirements of the tender, go to the website where the tender is hosted and submit your bid.

This website contains links to other websites that we do not control or maintain. We are not responsible for the content of these sites. We provide these links for your convenience only, and do not necessarily endorse their content.

Before entering into a contract you need to apply for any necessary export licences, which can include applications to trade in certain goods. You should also make your own enquiries and be satisfied by the accuracy of any information supplied to you.

This opportunity has been translated from its original language. You should check if you need to apply in the original language.

Go to third party website
Is there anything wrong with this page?